311,349 Shares in Teleflex Incorporated $TFX Purchased by Diamond Hill Capital Management LLC Investment Advisor

Key Points

• Diamond Hill Capital Management purchased 311,349 Teleflex shares worth approximately $39.5 million, taking a 0.70% stake. Institutional investors and hedge funds collectively own 95.62% of the company.
• Teleflex exceeded quarterly expectations, reporting $1.76 in EPS versus the $1.28 consensus estimate and $570.3 million in revenue, up 28.9% year over year. The company provided fiscal 2026 EPS guidance of $6.90 to $7.20.
• Analysts’ consensus rating remains Hold, with an average price target of $151.80; the stock recently traded near $136.98. Teleflex also declared a quarterly dividend of $0.34 per share, equivalent to a 1.0% annual yield.

Diamond Hill Capital Management LLC Investment Advisor purchased a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 311,349 shares of the medical technology company's stock, valued at approximately $39,467,000. Diamond Hill Capital Management LLC Investment Advisor owned 0.70% of Teleflex as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Janus Henderson Group PLC boosted its stake in Teleflex by 1.1% in the 1st quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company's stock valued at $513,281,000 after buying an additional 45,199 shares in the last quarter. AQR Capital Management LLC raised its stake in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock worth $287,603,000 after acquiring an additional 1,956,811 shares in the last quarter. State Street Corp raised its stake in Teleflex by 1.5% during the fourth quarter. State Street Corp now owns 1,478,776 shares of the medical technology company's stock worth $180,470,000 after acquiring an additional 22,111 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Teleflex by 0.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company's stock valued at $152,630,000 after acquiring an additional 5,051 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of Teleflex by 10.6% during the fourth quarter. Geode Capital Management LLC now owns 985,684 shares of the medical technology company's stock valued at $120,312,000 after acquiring an additional 94,679 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on TFX shares. Royal Bank Of Canada raised shares of Teleflex from a "sector perform" rating to an "outperform" rating and upped their target price for the stock from $135.00 to $155.00 in a report on Friday, May 8th. Mizuho boosted their price target on shares of Teleflex from $140.00 to $145.00 and gave the company a "neutral" rating in a research report on Wednesday, July 15th. Wells Fargo & Company boosted their price target on shares of Teleflex from $130.00 to $138.00 and gave the company an "equal weight" rating in a research report on Friday, May 8th. Wall Street Zen raised shares of Teleflex from a "sell" rating to a "hold" rating in a research note on Sunday, August 9th. Finally, Zacks Research raised shares of Teleflex from a "strong sell" rating to a "hold" rating in a report on Tuesday, April 28th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $151.80.

Teleflex Trading Down 0.1%

TFX opened at $136.98 on Monday. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. The stock has a market capitalization of $5.80 billion, a PE ratio of -5.88, a PEG ratio of 0.91 and a beta of 0.81. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $145.00. The firm has a 50-day moving average price of $132.38 and a two-hundred day moving average price of $123.81.

Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. During the same period in the prior year, the business earned $3.73 earnings per share. Teleflex's quarterly revenue was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 7.26 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex's dividend payout ratio (DPR) is presently -5.84%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source